Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors.
about
AAV's anatomy: roadmap for optimizing vectors for translational successHuman immunodeficiency virus-1 Nef expression induces intracellular accumulation of multivesicular bodies and major histocompatibility complex class II complexes: potential role of phosphatidylinositol 3-kinaseDistinct roles of adenovirus vector-transduced dendritic cells, myoblasts, and endothelial cells in mediating an immune response against a transgene product.Preexisting immunity to adenovirus in rhesus monkeys fails to prevent vector-induced toxicity.Transduction of skeletal muscles with common reporter genes can promote muscle fiber degeneration and inflammationThe use of gene transfer for the protection and repair of salivary glands.Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy.Immune responses to adeno-associated virus and its recombinant vectors.miRNA-mediated silencing in hepatocytes can increase adaptive immune responses to adenovirus vector-delivered transgenic antigensInduction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells.Safety of adeno-associated virus gene therapy vectors: a current evaluation.A nonproliferating parvovirus vaccine vector elicits sustained, protective humoral immunity following a single intravenous or intranasal inoculationSystemic protein delivery by muscle-gene transfer is limited by a local immune response.Immune responses to gene therapy vectors: influence on vector function and effector mechanisms.Liver gene therapy: advances and hurdles.Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD).Intranasal vaccination with AAV5 and 9 vectors against human papillomavirus type 16 in rhesus macaquesT-cell immunity generated by recombinant adenovirus vaccines.Liver-specific microRNA-122 target sequences incorporated in AAV vectors efficiently inhibits transgene expression in the liver.Silencing of T lymphocytes by antigen-driven programmed death in recombinant adeno-associated virus vector-mediated gene therapy.Regulatory function of in vivo anergized CD4(+) T cellsImmunity to adeno-associated virus vectors in animals and humans: a continued challenge.The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice.Tailored transgene expression to specific cell types in the central nervous system after peripheral injection with AAV9.The complex and evolving story of T cell activation to AAV vector-encoded transgene products.Improving adenovirus based gene transfer: strategies to accomplish immune evasion.The Skeletal Muscle Environment and Its Role in Immunity and Tolerance to AAV Vector-Mediated Gene Transfer.Lack of immunotoxicity after regional intravenous (RI) delivery of rAAV to nonhuman primate skeletal muscle.Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus.Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.Genetic manipulations of adenovirus type 5 fiber resulting in liver tropism attenuation.Direct comparison of four adeno-associated virus serotypes in mediating the production of antiangiogenic proteins in mouse muscle.The maturation of murine dendritic cells induced by human adenovirus is mediated by the fiber knob domain.Mir-142-3p target sequences reduce transgene-directed immunogenicity following intramuscular adeno-associated virus 1 vector-mediated gene delivery.Effect of tolerance induction to immunodominant T-cell epitopes of Sendai virus on gene expression following repeat administration to lung.Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors.Major role of local immune responses in antibody formation to factor IX in AAV gene transfer.Fabrication of poly(lactide-co-glycolide) scaffold filled with fibrin gel, mesenchymal stem cells, and poly(ethylene oxide)-b-poly(L-lysine)/TGF-β1 plasmid DNA complexes for cartilage restoration in vivo.
P2860
Q33659389-12DDCE65-116A-41D8-B824-8175C8CA7FF9Q33763110-D2DFD555-398B-4080-AF43-76D09FAEA587Q34333200-2CC726C2-D19F-45EC-B5BE-26660E7F5788Q34365087-858D4253-B3EF-43F6-B0D3-021B73303184Q34517044-4BA0B9DC-3CA8-45BD-B52F-4AF0CC120D26Q34806563-5D534D30-3165-4EF5-9335-710C2EFBAC87Q35131227-71DEC818-1284-48AD-BE20-E5107B89C4F3Q35131229-7BF2E0A5-159F-444E-AA5E-F92E91306A4EQ35144457-8AD4EAB2-47FC-4CCA-AA8B-CE6BF9B28C4CQ35186003-8B0B1B54-4A79-48E6-99D1-2CD987CA0066Q35194547-8300402F-2CAE-43C2-92F8-77678B2774BDQ35543174-F2E64390-57E1-4F7C-9F02-EB4968F74B38Q35847626-56665641-C109-442F-918A-239D0AF8EF73Q35904408-86038836-BC82-4BA6-84FD-8EF7AF8E6749Q35904443-2DF34F99-ACBB-437E-B4DB-4D0B8E5815AEQ35904461-82160F73-A6F9-48EB-9761-94088584C040Q36114234-0570D4C3-B3D5-4BAD-ABB4-E0887288A938Q36837129-6B1A9F45-8C13-43B4-9620-EB25A42034F5Q36940126-DA7EEB44-5A24-4484-8535-CBDA3BB11C94Q37066228-25BE6A0A-30BD-49F1-8EC5-9DDDFE4E0351Q37113443-3F4DE473-C64A-4CAE-AE16-A41000C34DC9Q37127246-67088123-ED1A-4120-B114-3229E29AB390Q37286686-8FB31A93-1ED8-4B32-BE31-77178F185561Q37481531-84C72A43-7648-4375-9E3D-5E5BE2ACB37EQ37814051-69E25598-624A-4877-BCE5-396F47AA9EFEQ37945219-3ED41A64-17CC-479A-BBFF-B5B3D568CED3Q38539938-59ABD9DC-372B-4B65-9AC6-37560D75026EQ39639059-35A77561-3435-4C6B-A7F9-C1BCB6F4E695Q39685864-8652E66A-D69B-47E4-AEAD-9670BCE207C2Q40379085-2452D512-BA1B-4C85-89A1-E6A0AE3FBF61Q40672499-9B16EB7A-12A0-4030-BB19-C0546B192D72Q43427810-24170E4F-C010-4A80-92F0-FF4F4A359E86Q43504654-F148EE7A-1F82-4C18-AD58-268CD2083E79Q44861538-15983AF3-077A-4100-AACB-9C252EB8B779Q45422036-E739A26C-B6B3-4DCB-A0B8-DC8108BE13EBQ45736630-34A99CF1-F1BB-4705-9642-A8D9B92892F8Q45883516-200FFC47-B41A-4597-B6E3-F76931B09FADQ45886048-53048C42-C1AD-45E4-A99C-61207A084487
P2860
Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Successful interference with c ...... by recombinant viral vectors.
@en
Successful interference with c ...... by recombinant viral vectors.
@nl
type
label
Successful interference with c ...... by recombinant viral vectors.
@en
Successful interference with c ...... by recombinant viral vectors.
@nl
prefLabel
Successful interference with c ...... by recombinant viral vectors.
@en
Successful interference with c ...... by recombinant viral vectors.
@nl
P2093
P2860
P1433
P1476
Successful interference with c ...... by recombinant viral vectors.
@en
P2093
P2860
P304
P356
10.1128/JVI.75.1.269-277.2001
P407
P577
2001-01-01T00:00:00Z